GESTIÓN EN SALUD PÚBLICA: Public Meeting on Patient-Focused Drug Development for Long COVID - 04/25/2023 | FDA

jueves, 16 de marzo de 2023

Public Meeting on Patient-Focused Drug Development for Long COVID - 04/25/2023 | FDA

Public Meeting on Patient-Focused Drug Development for Long COVID - 04/25/2023 | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)